Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...

From 2010 to 2020, breast cancer deaths among women ages 20–49 declined significantly across all breast cancer subtypes and ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

TNX-1700 is in preclinical development for gastric and colorectal cancers ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today outlined a framework for a ...

Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

A new, small cancer study may give hope to patients with solid tumors in the stomach, esophagus or rectum. The standard ...

The AACR meeting was full of promising data on the vaccine against cervical cancer, a lung cancer drug and the next ...

Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, will present preclinical data from its STX-003 program at the 2025 annual meetings of the ...

With the American Association for Cancer Research’s annual conference now underway, oncology researchers can expect ...

A new single-cell reference atlas of normal hematopoiesis has helped researchers identify novel acute myeloid leukemia cell ...